Literature DB >> 3924255

Torsade de pointes induced by sotalol despite therapeutic plasma sotalol concentrations.

R Krapf, M Gertsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3924255      PMCID： PMC1415932          DOI： 10.1136/bmj.290.6484.1784-a

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  5 in total

1.  Observations on the efficacy and pharmacokinetics of sotalol after oral administration.

Authors:  H C Brown; S G Carruthers; J G Kelly; D G McDevitt; R G Shanks
Journal:  Eur J Clin Pharmacol       Date:  1976-03-22       Impact factor: 2.953

2.  Human pharmacokinetics of sotalol.

Authors:  M Anttila; M Arstila; M Pfeffer; R Tikkanen; V Vallinkoski; H Sundquist
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1976-07

3.  Prolongation of the Q-T interval caused by sotalol--possible association with ventricular tachyarrhythmias.

Authors:  M Laakso; P J Pentikäinen; K Pyörälä; P J Neuvonen
Journal:  Eur Heart J       Date:  1981-08       Impact factor: 29.983

4.  Sotalol and prolonged Q-Tc interval.

Authors:  P J Neuvonen; E Elonen; A Tanskanen; J Tuomilehto
Journal:  Lancet       Date:  1981-08-22       Impact factor: 79.321

5.  Sotalol-induced torsade de pointes.

Authors:  K H Kuck; K P Kunze; N Roewer; W Bleifeld
Journal:  Am Heart J       Date:  1984-01       Impact factor: 4.749
  5 in total
  6 in total

1.  Torsade de pointes after astemizole overdose.

Authors:  T M Craft
Journal:  Br Med J (Clin Res Ed)       Date:  1986-03-08

Review 2.  Sotalol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use.

Authors:  B N Singh; P Deedwania; K Nademanee; A Ward; E M Sorkin
Journal:  Drugs       Date:  1987-09       Impact factor: 9.546

3.  Sotalol in patients with life-threatening ventricular tachyarrhythmias.

Authors:  H J Trappe; H Klein; P Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1990-10       Impact factor: 3.727

4.  Sotalol-induced torsade de pointes: management with magnesium infusion.

Authors:  M A Arstall; J T Hii; R G Lehman; J D Horowitz
Journal:  Postgrad Med J       Date:  1992-04       Impact factor: 2.401

Review 5.  Sotalol. An updated review of its pharmacological properties and therapeutic use in cardiac arrhythmias.

Authors:  A Fitton; E M Sorkin
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 6.  QT-interval prolonging drugs: mechanisms and clinical relevance of their arrhythmogenic hazards.

Authors:  M Zehender; S Hohnloser; H Just
Journal:  Cardiovasc Drugs Ther       Date:  1991-04       Impact factor: 3.727
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.